TAKEUCHI MFG in focus on upward earnings revision and aggressive shareholder returns
TAKEUCHI MFG.CO.,LTD. <6432> shares are drawing investor attention. In October, it raised its consolidated operating profit forecast for the fiscal year ending February 2027 to 44.5 billion yen from 37.3 billion yen (up 18.1% year-on-year). Sales of construction machinery have been solid in North America and Europe, and it now expects full-year earnings to swing to a year-on-year gain. Alongside the revision, TAKEUCHI MFG raised its dividend forecast by 25 yen to 245 yen per share (versus 210 yen in the prior fiscal year), while announcing a share buyback of up to 2.2 million shares (4.8% of outstanding shares excluding treasury shares) or 15 billion yen. Its proactive shareholder return policy has also been well received by the market.
With shares trading at a price-to-earnings ratio of about 11 times and a dividend yield of around 3.3%, the valuation remains attractive, suggesting further upside from current levels.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
-
TSUBAKIMOTO CHAIN ranks 3rd in 'rising sell forecasts' on Minkabu individual investor predictions
Thu Nov 5, 2026 10:28 am JST Catalyst -
Forex summary: Dollar struggles above 158.10 yen amid lack of aggressive buying
Thu Nov 5, 2026 10:17 am JST Currency -
TOYOTA MOTOR surges on hopes Trump administration will ease hardline trade stance, lifting auto stocks
Thu Nov 5, 2026 10:11 am JST Catalyst -
Kotobuki Spirits surges to new all-time high as H1 operating profit rises 23%
Thu Nov 5, 2026 10:10 am JST Catalyst -
ZERIA PHARMA surges as first-half operating profit rises 55%, year-end dividend forecast raised
Thu Nov 5, 2026 10:02 am JST Catalyst -
TSE Prime market breadth as of 10:00 a.m.: 1,249 gainers, 285 decliners
Thu Nov 5, 2026 10:04 am JST Market -
Kioxia falls for fourth straight session, drops below 10,000 yen again as selling pressure on AI and semiconductor stocks persists after U.S. midterm elections
Thu Nov 5, 2026 10:00 am JST Catalyst -
Japan Medical Dynamic Marketing shares hit limit-down on forecast swing to net loss and dividend cancellation
Thu Nov 5, 2026 9:55 am JST Catalyst -
Astellas Pharma surges to all-time high after raising full-year guidance and iPS cell therapy trial report
Thu Nov 5, 2026 9:54 am JST Catalyst -
LTV-X opens at 700 yen, 23% above IPO price
Thu Nov 5, 2026 9:50 am JST Catalyst